Related Experiment Video
Updated: Mar 31, 2026
Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
A Multinational Survey on Actual Diagnostics and Treatment of Subacute Sclerosing Panencephalitis
Martin Häusler1, Ayse Aksoy2, Michael Alber3
1Division of Pediatric Neurology and Social Pediatrics, Department of Pediatrics, University Hospital RWTH Aachen, Aachen, Germany.
Abstract:
Subacute sclerosing panencephalitis (SSPE) is a chronic infection of the central nervous system caused by the measles virus (MV). Its prevalence remains high in resource poor countries and is likely to increase in the Northern Europe as vaccination rates decrease. Clinical knowledge of this devastating condition, however, is limited. We therefore conducted this multinational survey summarizing experience obtained from more than 500 patients treated by 24 physicians in seven countries. SSPE should be considered in all patients presenting with otherwise unexplained acquired neurological symptoms. In most patients, the diagnosis will be established by the combination of typical clinical symptoms (characteristic repetitive myoclonic jerks), a strong intrathecal synthesis of antibodies to MV and typical electroencephalogram findings (Radermecker complexes). Whereas the therapeutic use of different antiviral (amantadine, ribavirin) and immunomodulatory drugs (isoprinosine, interferons) and of immunoglobulins has been reported repeatedly, optimum application regimen of these drugs has not been established. This is partly due to the absence of common diagnostic and clinical standards focusing on neurological and psychosocial aspects. Carbamazepine, levetiracetam, and clobazam are the drugs most frequently used to control myoclonic jerks. We have established a consensus on essential laboratory and clinical parameters that should facilitate collaborative studies. Those are urgently needed to improve outcome.
Insights
Subacute sclerosing panencephalitis (SSPE), a measles virus (MV) central nervous system infection, requires greater clinical attention. This multinational survey highlights diagnostic criteria and treatment approaches for SSPE, emphasizing the need for standardized care to improve patient outcomes.
Area of Science:
- Neurology
- Infectious Diseases
- Virology
Background:
- Subacute sclerosing panencephalitis (SSPE) is a chronic, devastating central nervous system infection caused by the measles virus (MV).
- Prevalence is high in low-resource settings and may increase in Europe due to declining measles vaccination rates.
- Limited clinical knowledge and standardized diagnostic/treatment protocols hinder effective management.
Purpose of the Study:
- To summarize clinical experience with over 500 Subacute sclerosing panencephalitis patients from a multinational survey.
- To establish consensus on essential diagnostic and clinical parameters for SSPE.
- To identify key challenges and needs for improving SSPE patient outcomes.
Main Methods:
- Multinational survey involving 24 physicians across seven countries.
- Summarization of clinical data from over 500 patients diagnosed with SSPE.
- Review of diagnostic criteria including clinical symptoms, intrathecal measles virus antibody synthesis, and electroencephalogram findings.
Main Results:
- SSPE should be suspected in patients with unexplained acquired neurological symptoms, particularly myoclonic jerks.
- Diagnosis is typically confirmed by characteristic symptoms, measles virus antibody synthesis, and specific EEG patterns.
- Commonly used medications for myoclonic jerks include carbamazepine, levetiracetam, and clobazam.
Conclusions:
- Standardized diagnostic and clinical approaches are crucial for advancing SSPE research and improving patient outcomes.
- Further collaborative studies are urgently needed to establish optimal therapeutic regimens for antiviral and immunomodulatory drugs.
- Consensus on essential parameters will facilitate future research and enhance the management of this rare neurological disorder.
More Related Videos
Related Concept Videos
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:29Chronic Pancreatitis II: Collaborative Care
Assessment: